1. Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes
- Author
-
Bruce H. R. Wolffenbuttel, Diederick E. Grobbee, Karly Hamulyák, R. van Oerle, Ronald P. Stolk, Paul Leurs, Interne Geneeskunde, RS: NUTRIM School of Nutrition and Translational Research in Metabolism, Life Course Epidemiology (LCE), Lifestyle Medicine (LM), and Center for Liver, Digestive and Metabolic Diseases (CLDM)
- Subjects
VONWILLEBRAND-FACTOR ,Blood Glucose ,Male ,medicine.medical_specialty ,VON-WILLEBRAND-FACTOR ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Lipoproteins ,Thrombomodulin ,Type 2 diabetes ,PLASMINOGEN-ACTIVATOR INHIBITOR-1 ,Impaired glucose tolerance ,chemistry.chemical_compound ,Insulin resistance ,Tissue factor pathway inhibitor ,NIDDM ,Internal medicine ,Diabetes mellitus ,von Willebrand Factor ,Internal Medicine ,medicine ,Humans ,HUMAN-PLASMA ,ALBUMIN EXCRETION ,Aged ,Advanced and Specialized Nursing ,Hemostasis ,business.industry ,Insulin ,Glucose Tolerance Test ,Middle Aged ,medicine.disease ,INSULIN ,Endocrinology ,chemistry ,Diabetes Mellitus, Type 2 ,CARDIOVASCULAR-DISEASE ,Plasminogen activator inhibitor-1 ,Tissue Plasminogen Activator ,cardiovascular system ,RISK-FACTORS ,Female ,Endothelium, Vascular ,Insulin Resistance ,business ,Biomarkers ,FIBRINOLYTIC-ACTIVITY - Abstract
OBJECTIVE—Impaired glucose tolerance (IGT) is believed to be a prediabetic phase that precedes the development of type 2 diabetes. In elderly subjects, IGT and diabetes are both independently associated with the occurrence of cardiovascular disease. Endothelial damage precedes atherosclerotic changes of the vascular wall. Therefore, several markers of endothelial dysfunction were examined in elderly subjects with IGT and elderly patients with type 2 diabetes. RESEARCH DESIGN AND METHODS—Von Willebrand factor (vWF), tissue plasminogen activator (t-PA), plasminogen activator inhibitor type-1 (PAI-1), and thrombomodulin were studied as markers of endothelial dysfunction in a population-based study of elderly subjects with normal glucose tolerance (NGT) or IGT and type 2 diabetes. In addition to these endothelium-dependent factors, we also investigated tissue factor pathway inhibitor (TFPI) activity in relation to metabolic parameters and cardiovascular risk factors. RESULTS—All data were adjusted for age. Increased levels of vWF antigen, t-PA antigen, and PAI-1 activity were seen in the IGT and diabetic group compared with the NGT group. TFPI activity and thrombomodulin levels were increased in all elderly subjects, and no differences were seen between the groups. There was a positive association between HbA1c and TFPI activity and vWF antigen. Fasting blood glucose levels correlated with vWF antigen, t-PA antigen, and PAI-1 activity, whereas urine albumin excretion correlated with TFPI activity, vWF antigen, and PAI-1 activity. Serum insulin levels correlated strongly not only with vWF antigen and t-PA antigen but also with PAI-1 activity. This correlation did not change after further adjustment for serum glucose and HbA1c, which may suggest that in the elderly subjects, impaired fibrinolysis is probably associated with insulin resistance. There were no associations between the endothelium-dependent hemostatic factors and lipids, except for a negative correlation between HDL cholesterol and thrombomodulin. CONCLUSIONS—In elderly subjects with IGT, several endothelium-dependent hemostatic factors are already consistently increased, indicating endothelial damage in this stage.
- Published
- 2002